Editorial: Non-cellular immunotherapies in pediatric malignancies
- PMID: 38449864
- PMCID: PMC10915082
- DOI: 10.3389/fimmu.2024.1379278
Editorial: Non-cellular immunotherapies in pediatric malignancies
Keywords: antibodies; cancer; checkpoint inhibition; immunotherapy; pediatrics; vaccines.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Non-cellular immunotherapies in pediatric malignancies
Similar articles
-
Immunotherapy in pediatric malignancies: current status and future perspectives.Future Oncol. 2014;10(9):1659-78. doi: 10.2217/fon.14.62. Future Oncol. 2014. PMID: 25145434 Free PMC article. Review.
-
Immunotherapies for pediatric cancer: current landscape and future perspectives.Cancer Metastasis Rev. 2019 Dec;38(4):573-594. doi: 10.1007/s10555-019-09819-z. Cancer Metastasis Rev. 2019. PMID: 31828566 Free PMC article. Review.
-
Immunotherapy approaches for rare pediatric solid tumors: advances and future directions.Curr Opin Pediatr. 2023 Feb 1;35(1):63-74. doi: 10.1097/MOP.0000000000001206. Epub 2022 Nov 24. Curr Opin Pediatr. 2023. PMID: 36420774 Review.
-
Cancer immunotherapies, their safety and toxicity.Expert Opin Drug Saf. 2013 Sep;12(5):631-45. doi: 10.1517/14740338.2013.795944. Epub 2013 May 14. Expert Opin Drug Saf. 2013. PMID: 23668362 Review.
-
Nouvelles perspectives dans l’immunothérapie des cancers pédiatriques.Bull Cancer. 2018 Dec;105 Suppl 1:S68-S79. doi: 10.1016/S0007-4551(18)30392-8. Bull Cancer. 2018. PMID: 30595201 Review. French.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical